Honglei Luo

机构：Xuzhou Medical College, Huaian First People’s Hospital, Second People’s Hospital of Huai’an, Nanjing Medical University · ORCID：0000-0003-0551-0651

发表论文 17 篇 · 总被引 271 次 · h-index 9

代表论文

• Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 82)
• Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation (2015 · Oncotarget · 被引 58)
• Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial (2020 · British Journal of Cancer · 被引 29)
• Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer (2018 · European Journal of Cancer · 被引 28)
• Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma (2020 · JAMA Network Open · 被引 25)
• Urea promotes alkaline anaerobic fermentation of waste activated sludge for hydrogen production (2024 · Bioresource Technology · 被引 15)